Toronto Dominion Bank Fibrogen Inc Transaction History

Toronto Dominion Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 14, 2024	BUY	$2.49 - $20.59 $224 - $1,853	90 New	90 $0
Q2 2023 Aug 10, 2023	BUY	$2.49 - $20.59 $224 - $1,853	90 New	90 $0
Q1 2022 May 09, 2022	SELL	$12.02 - $16.79 $1.56 Million - $2.18 Million	-130,121 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$9.93 - $15.39 $1.29 Million - $2 Million	130,121 New	130,121 $1.84 Million

46.8M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $53.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.